Avalon GloboCare Corp. Logo

Avalon GloboCare Corp.

Develops cell-based immunotherapies and provides precision diagnostics and lab services.

ALBT | US

Overview

Corporate Details

ISIN(s):
US05344R3021 (+1 more)
LEI:
Country:
United States of America
Address:
4400 ROUTE 9, 7728 FREEHOLD

Description

Avalon GloboCare Corp. is a commercial-stage company dedicated to developing and delivering transformative healthcare solutions. The company's activities are centered on two main areas: advancing cell-based immunotherapies and providing precision diagnostics with clinical laboratory services. Its therapeutic development focuses on immune effector cell therapies, including Chimeric Antigen Receptor T-cell (CAR-T) technology. In diagnostics, its core technology platforms include the KetoAir™ breathalyzer, which utilizes nanosensor technology, and the QTY protein design platform, a joint intellectual property with the Massachusetts Institute of Technology (MIT). The company also operates clinical laboratories offering an extensive menu of services, such as general bloodwork, anatomic pathology, urine toxicology, and pharmacogenomics (PGx) testing.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Avalon GloboCare Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Avalon GloboCare Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Avalon GloboCare Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.